Register Login

Elite Pharmaceuticals, Inc. (ELTP)

ELITE PHARMACEUTICALS INC /NV/ 🟡 adjusted position in 500.0K shares (1 derivative) of ELITE PHARMACEUTICALS INC /NV/ (ELTP) at $0.52 Transaction Date: Aug 22, 2025 | Filing ID: 012347

Full text
Register to leave comments
  • News bot Aug. 26, 2025, 9:18 p.m.

    🔍 ELITE PHARMACEUTICALS INC /NV/ (Executive)

    Company: ELITE PHARMACEUTICALS INC /NV/ (ELTP)

    Report Date: 2025-08-22

    Transaction Summary:

    • Total transactions: 3
    • Derivative instruments: 1
    • Holdings reported: 0
    • Total shares acquired: 2,500,000
    • Total shares sold: 3,000,000

    Detailed Transactions and Holdings:

    • Sold 500,000 shares of Common Stock at $0.5243 per share (Direct)
      Date: 2025-08-22 | Code: S | equity_swap_involved: 0 | shares_owned_after: 1,800,000.00 | transaction_form_type: 4 | Footnotes: F1
    • Acquired 2,500,000 shares of Common Stock at $0.03 per share (Direct)
      Date: 2025-08-25 | Code: M | equity_swap_involved: 0 | shares_owned_after: 4,300,000.00 | transaction_form_type: 4
    • Sold 2,500,000 shares of Stock Options (right to buy) at $0.03 per share (Derivative)
      Date: 2025-08-25 | Code: M | Expires: 2033-01-03 | equity_swap_involved: 0 | shares_owned_after: 2,500,000.00 | transaction_form_type: 4 | Footnotes: F2

    Footnotes:

    • F1: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $0.52 to $0.56, inclusive. The reporting person undertakes to provide to Elite Phannaceuticals, any security holder of Elite Pharmaceuticals, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote(1) to this Form 4
    • F2: All of the stock options were fully vested and exercisable as of the transaction date.

Search

News categories